The District of Columbia Alcoholic Beverage and Cannabis Board has imposed a 30-day suspension on KLM, LLC, operating as Doobie District on U Street, for selling medical cannabis to individuals without proper verification and falsifying records in the METRC tracking system. Issued February 11, 2026, this ruling underscores the critical need for strict compliance in DC's medical cannabis program to protect patient safety and prevent diversion.
Undercover Probe Reveals Serious Violations
An investigation launched May 9, 2025, by the Alcoholic Beverage and Cannabis Administration (ABCA) exposed lapses at the 1526 U Street, NW dispensary. Undercover agents made two controlled purchases of medical cannabis without showing patient cards or caregiver status, confirming staff skipped mandatory ID checks.
- Products bore labels with a Doobie District employee's name and ID, not the buyers'.
- The employee's METRC account showed purchases exceeding the 8-ounce, 30-day patient limit.
- Two other accounts were oversold using the same credentials.
These actions violated 22-C DCMR § 5709.5 (dispensing to non-qualified individuals) and § 5615.3 (false METRC entries), compromising the seed-to-sale system's integrity designed to track products from cultivation to sale.
Board's Response Balances Accountability and Remediation
In Order No. 2026-211, the Board sustained both charges after owner Peter Murillo stipulated to the facts but argued for leniency. Doobie District fired implicated staff, retrained others, and added personal oversight like weekly sales tracking. Despite this, the Board stressed licensee responsibility for supervision, opting for suspension over revocation.
- 30-day medical cannabis retailer license suspension.
- Mandatory ABCA-approved training for ownership within 60 days.
- Potential reimposition for non-compliance.
The decision reflects a measured approach, recognizing internal fixes while signaling zero tolerance for negligence.
Implications for Patient Safety and Market Integrity
DC's medical cannabis framework prioritizes verified access to mitigate risks like overconsumption or black-market leakage, where untracked products fuel illicit trade. Falsified METRC data erodes trust in a system proven to reduce diversion by up to 90% in compliant states, per industry analyses. This case highlights ongoing challenges in a maturing market: rapid growth strains verification protocols, with ABCA reporting similar probes rising 25% since 2024.
For patients relying on cannabis for chronic pain or epilepsy—conditions affecting over 10,000 registered DC users—such breaches threaten therapeutic reliability and public health. Stricter enforcement could deter violations, fostering a safer ecosystem amid federal reform debates. Doobie District's saga serves as a cautionary tale: compliance isn't optional in safeguarding vulnerable consumers.
